RecallDepth
Class II Terminated

Fluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- count bottles (NDC 50111-648-03), Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960

Company
Teva Pharmaceuticals Usa
Recall Initiated
April 13, 2015
Posted
May 6, 2015
Recall Number
D-0971-2015
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Horsham, PA, United States

Reason for Recall

Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.

Distribution

Nationwide

Lot / Code Info

Lot #: a) 6A208123, Exp 8/2015; b) 6A208121, Exp 8/2015.

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls